≡

Multiplex Assay Kit for Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay)

HYPG; LIG; UBE2K; Ubiquitin-Conjugating Enzyme E2K; Ubiquitin carrier protein; Ubiquitin-protein ligase

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 88-96 91
EDTA plasma(n=5) 78-104 89
heparin plasma(n=5) 92-105 101
sodium citrate plasma(n=5) 78-103 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-104% 80-94% 88-104% 93-105%
EDTA plasma(n=5) 93-102% 96-103% 80-99% 80-89%
heparin plasma(n=5) 90-99% 80-101% 80-93% 92-104%
sodium citrate plasma(n=5) 88-105% 78-91% 93-104% 78-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:HIP2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J Neural Transm (Vienna) CSF Nrf2 and HSPA8 in Parkinson’s disease patients with and without PubMed: 26526034
J Neural Transm (Vienna) CSF Nrf2 and HSPA8 in Parkinson&#039;s disease patients with and without LRRK2 gene mutations PubMed: 26526034
International Journal of Oncology Methylation‑associated silencing of miR‑128 promotes the development of esophageal cancer by targeting COX‑2 in areas with a high incidence of esophageal … Pubmed: 30535495
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPE601Hu01 Recombinant Huntingtin Interacting Protein 2 (HIP2) Positive Control; Immunogen; SDS-PAGE; WB.
PAE601Hu01 Polyclonal Antibody to Huntingtin Interacting Protein 2 (HIP2) WB; IHC; ICC; IP.
SEE601Hu ELISA Kit for Huntingtin Interacting Protein 2 (HIP2) Enzyme-linked immunosorbent assay for Antigen Detection.
LME601Hu Multiplex Assay Kit for Huntingtin Interacting Protein 2 (HIP2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CGE601Hu01 cDNA of Huntingtin Interacting Protein 2 (HIP2) PCR; Protein Expression; etc.